Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 21;21(4):715-22.
doi: 10.1021/bc900511j.

In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent

Affiliations

In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent

Charles Glaus et al. Bioconjug Chem. .

Abstract

A novel nanoparticle-based dual-modality positron emission tomograph/magnetic resonance imaging (PET/MRI) contrast agent was developed. The probe consisted of a superparamagnetic iron oxide (SPIO) core coated with PEGylated phospholipids. The chelator 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraacetic acid (DOTA) was conjugated to PEG termini to allow labeling with positron-emitting (64)Cu. Radiolabeling with (64)Cu at high yield and high purity was readily achieved. The (64)Cu-SPIO probes produced strong MR and PET signals and were stable in mouse serum for 24 h at 37 degrees C. Biodistribution and in vivo PET/CT imaging studies of the probes showed a circulation half-life of 143 min and high initial blood retention with moderate liver uptake, making them an attractive contrast agent for disease studies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Schematic representation dual-modality 64Cu-mSPIO. (B) Transmission electron micrograph of uniform monocrystalline superparamagnetic iron oxide nanoparticles. (C) Dynamic light scattering showing highly monodisperse populations of mSPIO before (closed bars) and after (open bars) encapsulation in PEGylated lipid micelle. (D) In vitro stability of 64Cu-mSPIO over the course of 24 hr incubation in 37 °C mouse serum.
Figure 2
Figure 2
Biodistribution data of dual-PET/MRI 64Cu-mSPIO (10 mg Fe/kg body weight) in BALB/c mice. Groups of mice (n = 4) were sacrificed at 10 min, 1 hr, 4 hr, and 24 hr and select organs were measured for activity. Data are expressed as percent injected dose per gram tissue (%ID/g, top) and percent injected dose per organ (%ID/organ, bottom) ± one standard deviation.
Figure 3
Figure 3
Coregistered microPET/microCT of BALB/c mice administered 100 μCi of 64Cu-mSPIOs (10 mg Fe/kg body weight, 100 μL injection volume). Whole body sagittal (A–E) and coronal (B–F) PET images are decay corrected and scaled by min/max frame: (A, B) 1 hr; (C, D) 4 hr; and (E, F) 24 hr post-injection.
Figure 4
Figure 4
PET and MR imaging of 64Cu-mSPIO phantoms. (A) T2-weighted image of 25 μg Fe/mL (top) and 10 μg Fe/mL (bottom) of 64Cu-labeled magnetic nanoparticles (scale bar corresponds to high and low iron concentration). (B) Decay-corrected microPET image of 25 μg Fe/mL (top) and 10 μg Fe/mL (bottom) of 64Cu-labeled magnetic nanoparticles (scale bar corresponds to high and low copper-64 concentration).

Similar articles

Cited by

References

    1. Czernin J, Allen-Auerbach M, Schelbert H. Improvements in Cancer Staging with PET/CT: Literature-Based Evidence as of September 2006. Journal of Nuclear Medicine. 2007;48:78S. - PubMed
    1. Judenhofer MS, Wehrl HF, Newport DF, Catana C, Siegel SB, Becker M, Thielscher A, Kneilling M, Lichy MP, Eichner M, Klingel K, Reischl G, Widmaier S, Rocken M, Nutt RE, Machulla HJ, Uludag K, Cherry SR, Claussen CD, Pichler BJ. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14:459–465. - PubMed
    1. Higuchi T, Anton M, Dumler K, Seidl S, Pelisek J, Saraste A, Welling A, Hofmann F, Oostendorp RA, Gansbacher B, Nekolla SG, Bengel FM, Botnar RM, Schwaiger M. Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart. J Nucl Med. 2009;50:1088–1094. - PubMed
    1. Xu H, Regino CA, Koyama Y, Hama Y, Gunn AJ, Bernardo M, Kobayashi H, Choyke PL, Brechbiel MW. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjug Chem. 2007;18:1474–1482. - PubMed
    1. Koyama Y, Talanov VS, Bernardo M, Hama Y, Regino CA, Brechbiel MW, Choyke PL, Kobayashi H. A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging. 2007;25:866–871. - PubMed

Publication types